We previously reported a novel monoclonal antibody KOR-SA3544 which predominantly reacted with a surface antigen (sSA3544) expressed on Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL). In the present study, we demonstrate that the antibody specifically recognized nonspecific cross-reacting antigen ( 
Introduction
We previously reported a monoclonal antibody KOR-SA3544, 1 which was reactive with a surface antigen expressed on Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) without exception (26/26 cases) . Although the leukemia cells from a part of Ph1-negative Bprecursor ALL (6/65) and acute non-lymphoid leukemia (16/56) reacted to this antibody on their surfaces, none of the leukemia cells from blast crisis of chronic myeloid leukemia (CML-BC) (0/9) and T-ALL (0/19) were reactive. In addition, flow cytometric two-color analysis using PE-conjugated anti-CD19 and FITC-conjugated KOR-SA3544 revealed a small population of double-labeled cells in light microscopically remission bone marrow (BM) of patients with Ph1-positive ALL, but not in BM of normal volunteers (less than 0.1%). 1 Thus, this antibody is useful not only for the diagnosis of Ph1-positive ALL as a first line of screening, but also for the detection of its minimal residual disease. Recently, it was also shown that demonstration of surface SA3544 antigen (sSA3544)-positive population (Ͼ3%) in Ph1-negative B-precursor ALL predicted the absence of TEL/AML1 chimeric transcript (0/18 cases) with very high specificity. The carcinoembryonic antigen (CEA) gene family forms a part of the immunoglobulin supergene family and encodes glycoproteins that share some of the antigenic epitopes present on CEA, which includes CEA, nonspecific crossreacting antigens (NCAs), biliary glycoprotein (BGP)1, and CEA gene member (CGM) antigens. [3] [4] [5] At the 7th international meeting on leukocyte typing (Boston, USA, 1993), some antigens belonging to the CEA family were newly classified as CD66, which consists of CD66a (BGP1), CD66b (NCA-95, CGM6 antigen), CD66c (NCA-50/90), and CD66e (CEA). 6 Several NCA antigens with similar but distinct biochemical properties have been identified in a variety of normal and malignant tissues or cells, including colon, lung, spleen, granulocytes and macrophages. 5 It is known that granulocytes express eight NCA species. 7 Of these, NCA-95 (CD66b) is a glycoprotein of 95 kDa and encoded by the CGM6 gene, 8 while NCA-50/90 (CD66c) is a similar glycoprotein which shows molecular mass of 50 or 90 kDa by different glycosylation of a common peptide core (35 kDa) encoded by the NCA gene. 8, 9 Since the antigen defined by KOR-SA3544 was 90-110 kDa in size on SDS-polyacrylamide electrophoresis and also highly expressed on granulocytes, CD66b (CD67 by previous classification) was first suspected as a candidate antigen that is recognized by KOR-SA3544 among several myeloid-associated antigens, but proved not as shown in our previous report. 1 In the present study, using the purified CEA family proteins and transfectants specifically expressing distinct CEA family antigens, we demonstrated that KOR-SA3544 was specifically reactive with NCA-50/90 (CD66c), but not with other members of the CEA family. We also showed that NCA-50/90 was invariably expressed in cytoplasm of various types of human leukemic cell lines regardless of the presence or absence of its surface expression.
Materials and methods

Cells
Granulocytes were isolated from healthy volunteers' peripheral blood using dextran sedimentation followed by density gradient centrifugation. Human leukemic cell lines established from three T-ALL (KOPT-4, -5, -6), three Ph1-negative B-precursor ALL (KOPN-32, -36, KOCL-33), two Ph1-positive ALL (KOPN-30bi, -57bi), and three CML-BC (NALM-1, KOPM-28, K562) were used in this study. NALM-1, KOPM-28 and K562 were all Ph1-positive and their natures were pre B-lymphoid, myelomonocytic and erythroid, respectively. All cell lines except for NALM-1 and K562 were established in our laboratory and have been reported previously. [10] [11] [12] HeLa cells transfected with vector alone or cDNA encoding various CEA-related antigens: BGP1 (CD66a), NCA-95 (CD66b), NCA-50/90 (CD66c), CGM1 (CD66d) and CEA (CD66e) were also used. 6, 13 Purification of NCA-50/90 and CEA NCA-50/90 and CEA were purified from human normal lung tissues and human colon adenocarcinoma cells, respectively, according to methods as reported previously. 14, 15 The purified NCA-50/90 contained the 50 kDa form more than 20-fold higher than the 90 kDa form.
Monoclonal antibodies (mAbs)
KOR-SA3544 (IgG1) was purified from ascites in our laboratory using protein A-agarose and was used throughout the study. FITC-conjugated KOR-SA3544 was obtained from MBL (Nagoya, Aichi, Japan). Anti-NCA-50/90 (CD66c) mAb (F106-88) (16) and anti-CEA (CD66e) mAb (F33-104) 17 which have been extensively characterized by Kuroki et al (Fukuoka University, Fukuoka, Japan), were used in several comparative studies. Anti-NCA-95 (CD66b) mAb (80H3) and antiCD66acde mAb (D14-HD11) which were characterized by Grunert et al 6 (Albert-Ludwigs University Freiburg, Freiburg, Germany), were also used in flow cytometric analysis. mAbs reactive with ␣-tubulin (TU-01) and CD29 (4B4) were purchased from Sanbio (Uden, The Netherlands) and Coulter Immunology (Hialeah, FL, USA), respectively.
Flow cytometric analysis
Normal granulocytes and a Ph1-positive leukemic cell line (KOPN-57bi) were incubated with normal mouse IgG (negative control), KOR-SA3544, anti-NCA-50/90 (F106-88), and anti-CD29 (positive control) on ice for 30 min. HeLa cells transfected with vector alone or cDNA encoding various CEArelated antigens were also incubated with normal mouse serum, KOR-SA3544, anti-CD66b (80H3), and antiCD66acde (D14-HD11). After washing with PBS, the cells were then incubated with FITC-labeled rabbit anti-IgG (MBL) on ice for 30 min. Cytofluorographic analysis was performed on a FACScaliber flow cytometer (Coulter).
Western blot analysis
Cells (5 × 10 6 ) were solubilized in lysis buffer (50 mM TrisHCl, pH 8.0 containing 1% Nonidet P-40, 150 mM NaCl, 5 mM EDTA, 1 mM PMSF, 0.2 TIU/ml aprotinin, and 10 mM iodoacetamide) for 15 min on ice. The cell lysates were separated on a 7.5% SDS-polyacrylamide gel under reducing conditions, and then transferred to nitrocellulose membrane. In some experiments, the membrane was vertically cut into several pieces for staining with different antibodies. After blocking of nonspecific reaction with TBST (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.05% Tween 20) containing 5% skim milk, the membrane was incubated with mouse IgG1 (negative control) or various mAbs (10 g/ml) for over night at room temperature. After washing with TBST, the membrane was incubated with alkaline phosphatase-labeled rabbit antimouse IgG (1:5000 dilution), purchased from Promega (Madison, WI, USA), for 1 h at room temperature. After washing again with TBST, alkaline phosphatase was developed by nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Promega) in 100 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl 2 . Purified NCA-50/90 and CEA (1 g/lane) were similarly run on a 7.5% SDS-polyacrylamide gel, transferred to nitrocellulose membrane, incubated with KOR-SA3544, anti-NCA-50/90 (F106-88), or anti-CEA (F33-104), and developed.
Immunofluorescent staining of fixed cells
Granulocytes and leukemic cell lines were fixed with 4% paraformhyde in 0.15 M cacodylate buffer (pH 7.4) for 30 min at room temperature. After washing twice with PBS, the cells were treated with PBS containing 0.05% Triton X-100 for 15 min, and then incubated with normal mouse IgG1 (negative control) or KOR-SA3544 (10 g/ml) for 2 h at 4°C. After washing three times, the cells were incubated with Cy2-labeled goat anti-mouse IgG (Amersham Japan, Tokyo, Japan) for 1 h at 4°C. The cells were then washed and mounted on glass slides with PBS containing glycerol. Observation was performed with a Leitz confocal microscope.
Immunogold staining of fixed cells
Cells were fixed in mixture of 4% paraformaldehyde and 0.25% glutaraldehyde in 0.15 M cacodylate buffer, pH 7.4 for 1 h at 4°C. After a wash with PBS, cells were dehydrated with graded dimethylformamide and embedded in LR White at −20°C. The resin was polymerized under UV light at −20°C for 24 h. Thin sections were cut on a diamond knife with an LKB Ultrotome and mounted on nickel grids. Sections were incubated with 0.5% BSA-PBS for 10 min, followed by overnight incubation with normal mouse IgG1 (negative control) or KOR-SA3544 (10 g/ml) at 4°C. Sections were then washed with PBS, followed by 30 min incubation with 15 nm gold conjugate of goat anti-mouse IgG (Zymed Laboratories, San Francisco, CA, USA) which had been diluted 10 times with 0.5% BSA-PBS. After drying in air, sections were contrasted with uranyl acetate and lead citrate, and examined with a Hitachi H600 electron microscope.
Results
Flow cytometric comparative analysis of KOR-SA3544 and anti-NCA-50/90 mAb
To examine whether KOR-SA3544 recognizes NCA-50/90 or not, we first performed the flow cytometric comparative analysis using a known anti-NCA-50/90 mAb (F106-88). As shown in Figure 1 , both KOR-SA3544 and anti-NCA-50/90 mAb were highly reactive with granulocytes and a Ph1-positive leukemic cell line (KOPN-57bi) although their fluorescence intensities were slightly different in the staining of KOPN-57bi. This result supported the possibility that KOR-SA3544 might recognize NCA-50/90. We thus performed the crossblocking study using both antibodies. Preincubation of granulocytes with unlabeled anti-NCA-50/90 mAb did not block or reduce their staining with FITC-conjugated KOR-SA3544, suggesting that both antibodies are reactive with dif-
Figure 1
Flow cytometric comparative analysis of KOR-SA3544 and anti-NCA-50/90 mAb. Granulocytes and Ph1-ALL cell line KOPN-57bi were stained with mouse IgG1 (negative control), KOR-SA3544, anti-NCA-50/90 mAb (F106-88), and anti-CD29 mAb (positive control) as described in Materials and methods, and analyzed on flow cytometry. The horizontal and vertical axes represent log fluorescence and cell number, respectively. ferent epitopes even though they recognize the same molecule NCA-50/90 (data not shown).
Comparative analysis of KOR-SA3544 and anti-NCA-50/90 on Western blot
We next performed the comparative analysis on Western blot. As shown in Figure 2 , both KOR-SA3544 and anti-NCA-50/90
Figure 2
Comparative analysis of KOR-SA3544 and anti-NCA-50/90 mAb on Western blot. The lysates of granulocytes (lanes 1-3) and Ph1-ALL cell line KOPN-57bi (lanes 4-5) were run on a 7.5% SDS-polyacrylamide gel, transferred to nitrocellulose. The membrane was cut into three pieces, and each of the pieces was incubated with mouse IgG1 (lanes 1,4) , KOR-SA3544 (lanes 2, 5), or anti-NCA-50/90 (F106-88) (lanes 3, 6) and developed as described in Materials and methods.
mAb (F106-88) revealed a broad band ranging from 90 to 110 kDa in the lysate of granulocytes and a sharp 90 kDa band in the lysate of a Ph1-positive leukemic cell line KOPN57bi. This result strongly suggested that both antibodies recognize the same antigen NCA-50/90.
Reactivity of KOR-SA3544 with purified NCA-50/90
To confirm the above result, we examined the reactivity of KOR-SA3544 with the purified NCA-50/90 on Western blot. As shown in Figure 3 , both KOR-SA3544 and anti-NCA-50/90 mAb (F106-88) visualized the marked 40-60 kDa and the faint 90 kDa bands in the lane in which the purified NCA-50/90 was applied, but no bands in the lane in which the purified CEA was applied. In contrast, anti-CEA mAb detected the
Figure 3
Comparative analysis of reactivity of KOR-SA3544, anti-NCA-50/90, and anti-CEA with purified NCA-50/90 and CEA on Western blot. Purified NCA-50/90 (lanes 1, 3, 5) and CEA (lanes 2, 4, 6) were run on a 7.5% SDS-polyacrylamide gel, transferred to nitrocellulose, incubated with KOR-SA3544 (lanes 1, 2) , anti-NCA-50/90 (lanes 3, 4) and anti-CEA (lanes 5, 6), and developed as described in Materials and methods.
180 kDa band only in the lane in which the purified CEA was applied. This result indicated that KOR-SA3544 recognized NCA-50/90 (CD66c).
Reactivity of KOR-SA3544 with transfectants expressing different CEA-related antigens
It is well known that several mAbs classified into anti-CD66 show a broad crossreactivity to various CEA-related antigens due to their structural similarities. Therefore, to clarify the specificity of KOR-SA3544, we tested its reactivity with transfectants expressing different CEA-related antigens on flow cytometry. The broadly crossreacting anti-CD66acde mAb (D14-HD11) and anti-CD66b mAb (80H3) were used as controls. As summarized in Table 1 , KOR-SA3544 was specifically reactive with the transfectant expressing NCA-50/90 (CD66c) but not with other transfectants. KOR-SA3544 was also not reactive with the transfectants expressing other CEA family members CGM7 and pregnancy-specific glycoprotein (PSG)1 (data not shown).
Detection of NCA-50/90 in human leukemic cell lines on Western blot
To address the possibility that some leukemic cell lines may contain NCA-50/90 in their cytoplasm, we examined the NCA-50/90 expression on Western blot using a representative sSA3544-negative leukemic cell line KOPT-5. As shown in Figure 4a , both KOR-SA3544 and anti-NCA-50/90 mAb (F106-88) detected the 90 kDa band identical to that detected in a sSA3544-positive leukemic cell line KOPN-57bi (Figure 2 ). We next tested nine sSA3544-negative leukemic cell lines derived from three T-ALL, three B-precursor ALL and three CML-BC for reactivity to KOR-SA3544 on Western blot. Granulocytes and sSA3544-positive cell lines (KOPN-30bi, KOPN-57bi) derived from Ph1-positive ALL were used as positive controls. As demonstrated in Figure 4b , all cell lines examined showed the identical 90 kDa band. The same results were also obtained in an additional 15 (T-or B-lymphoid 12, non-lymphoid three) sSA3544-negative human leukemic cell lines (data not shown), suggesting that these cell lines synthesize NCA-50/90 (CD66c) which is not accessible on the cell membrane. Table 1 Reactivity of KOR-SA3544 with transfectants expressing different CEA-related antigens (lanes 8,9) , and CML-BC cell lines (lanes 10-12) were run on a 7.5% SDS-polyacrylamide gel, transferred to nitrocellulose, incubated with KOR-SA3544, and developed as described in Materials and methods.
Immunofluorescent staining of NCA-50/90 in granulocytes and leukemic cell lines
To verify the distribution of NCA-50/90 in leukemic cell lines, we examined the reactivity of KOR-SA3544 with the fixed cell lines using indirect immunofluorescence. As visualized in Figure 5 , both granulocytes (a) and a Ph1-positive leukemic cell line KOPN-57bi (b) were stained with KOR-SA3544 strongly on the surface and weakly in cytoplasm, while a T cell line KOPT-5 (c) was stained diffusely and finely only in Immunofluorescent staining of fixed cells with KOR-SA3544. Granulocytes (a), Ph1-ALL cell line KOPN-57bi (b) and T-cell line KOPT-5 (c) were fixed with 4% paraformhyde. The cells were incubated with KOR-SA3544, and then with Cy2-labeled goat anti-mouse IgG as described in Materials and methods. Observation was performed with a Leitz confocal microscope.
cytoplasm. No significant stainings were detected with normal mouse IgG1 (data not shown).
Electroscopic immunogold staining of NCA-50/90 in granulocytes and leukemic cell lines
To further clarify the cytoplasmic distribution of NCA-50/90, we performed immunogold staining of this antigen and observed on an electromicroscope. As shown in Figure 6 , the cytoplasmic antigen was specifically present in primary and secondary granules in granulocytes (a) and in lysosomal granules of a Ph1-positive leukemic cell line KOPN-57bi (b). In contrast, NCA-50/90 antigen was diffusely present in cytoplasm but not in granules in a T cell line KOPT-5 (c). No significant gold particles were detected in granules and cytosol when stained with normal mouse IgG1 (data not shown). The sSA3544-positive (KOPN-30bi) and -negative (KOPN-32, KOPM-28) leukemic cell lines were also examined, and identical results were obtained (data not shown).
Discussion
In the present study, we showed that the antigen recognized by KOR-SA3544 is NCA-50/90 (CD66c). Although most mAbs classified into anti-CD66 are known to react with several structurally related antigens encoded by the CEA gene family members, the reactivity of KOR-SA3544 was specifically restricted to NCA-50/90. Molecular analysis of NCA-50/90 predicts a 108-residue amino terminal region (N domain) with homology to immunoglobulin variable regions which is followed by a single 178-amino acid region with high homology to immunoglobulin constant domains. 8, 18 The 24-amino acid C-terminal is thought to be processed post-translationally with the addition of a phosphatidylinositol glycan anchor. 19, 20 As a whole, the NCA gene shows about 90% sequence similarity at the nucleotide level to the CEA gene and thereby belongs to the CEA gene family within the immunoglobulin supergene family. The members of the CEA gene family are believed to function as adhesion molecules because of evidence such as homology with the neural cell adhesion molecule (N-CAM) and homotypic and heterotypic intercellular adhesion. 21, 22 The NCA-50/90 carries the sialyl Lewis-X carbohydrate antigen structure, ligand for the selection family cell-adhesion molecules, and is involved in adherence of granulocytes to activated endothelial cells. 23 The surface expression of NCA-50/90 on leukemic cells also may play a role in cellular survival and tissue infiltration via interactions with BM stromal cells and endothelial or interstitial cells of various tissues. In fact, CEA is reported to be involved in distant metastasis of cancer cells by enhancement of attachment to tissues. 24 According to the report by Hanenberg et al, 25 surface expression of CEA-related glycoproteins was shown in 80% of childhood ALL (12 of 15 cases). NCA-95 (CD66b) and CEA (CD66e) were not detectable at all, whereas BGP1 (CD66a) and NCA-50/90 (CD66c) were detected in five (38.5%) and 10 (76.9%) of 13 cases of B-precursor ALL, respectively. Considering the 10-20% reactivity of KOR-SA3544 with CD10-positive B-precursor ALL (cALL) without Ph1, 1 the high rate of NCA-50/90 expression in their report may be due to crossreactivity of mAbs used with the CEA members other than NCA-50/90. Alternatively, the NCA-50/90 epitope recognized by KOR-SA3544 may have more restricted distribution on surfaces of cALL cells compared with other anti-CD66c mAbs. It should be noted that high % expression of sSA3544 antigen (Ͼ50%) in cALL is considerably restricted to Ph1-positive ALL (mean expression 71.8%). 1 Although the report by Hrusak et al 2 showed sSA3544 expression (Ͼ3%) on leukemia cells in 18 of 49 cases (36.7%) of newly diagnosed Ph1-negative cALL, the population of sSA3544-positive blasts was lower than 50% in most positive cases, while it was 90% in one case of Ph1-positive cALL. Thus, high % expression of sSA3544 antigen in cALL is a useful marker for the diagnosis of Ph1-positive ALL as a first line of screening.
It was also shown in this study that NCA-50/90 was invariably present in cytoplasm of a variety of leukemic cell lines. Immunoelectromicroscopic examination revealed that the antigen distribution in cytoplasm was different among cell lines; mainly present in granules in Ph1-positive ALL cell lines and diffusely present in cytosol in sNCA-50/90-negative leukemic cell lines. The mechanism of intracellular transporting system for this antigen is unclear at present. However, considering the difference in cytoplasmic distribution between sNCA-50/90-positive and -negative leukemic cell lines, it appears that the antigen is first incorporated into granules and then transported to the surface. Since it was recently shown that specific molecules such as a small GTP-binding protein, phosphatidylinositol-3-phosphate, and proteins containing FYVE finger domain are important for protein sorting and transport from the late Golgi to lysosome, 26 there may exist the possibility that quantity, nature, or activity of molecules involved in this intracellular vesicle transport system is distinct between sNCA-50/90-positive and -negative leukemic cells, and thus cellular localization of NCA-50/90 differs among cell lines.
The CEA-related antigens are known to increase in serum Immunoelectromicroscopic examination of cytoplasmic distribution of the SA3544 antigen. Granulocytes (a), Ph1-ALL cell line KOPN-57bi (b) and T-cell line KOPT-5 (c) were fixed, dehydrated, embedded, and cut. Sections were first incubated with KOR-SA3544 over night, and then with goat anti-mouse IgG-conjugated gold as described in Materials and methods. Observation was carried out with a Hitachi H600 electron microscope. associated with malignant disorders. In particular, CEA has been widely used for the diagnosis of colon cancers and for important laboratory monitoring of these diseases. 3, 22, 24 Although it has been reported that NCA is elevated in sera of non-lymphoid leukemic patients, 27 ,28 the antibodies used had an uncertain specificity. Recently, using the specific enzymelinked immunosorbent assay (ELISA) method, NCA-50/90 was shown to be elevated in sera of some patients not only with breast, lung and colon cancers, but also with CML (10/14), AML (6/16) and CLL (4/22). 29 Accordingly, serum level of this antigen is expected to be high in some patients with ALL. We have just established a similar ELISA system for NCA-50/90 and our preliminary data supported the above possibility.
Thus, a serial determination of its serum levels may have clinical benefit as one of the laboratory markers to evaluate the disease status of lymphoid and non-lymphoid leukemias.
